Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.96
-2.7%
$1.23
$0.85
$2.22
$97.48M1.42732,139 shs904,666 shs
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$37.39
-1.3%
$36.83
$33.27
$60.89
$108.66M0.725,380 shs1,817 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.89
+5.0%
$1.83
$1.60
$4.67
$120.90M1.06504,403 shs630,530 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.74
+2.6%
$0.73
$0.63
$2.60
$34.70M0.81155,330 shs50,091 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-2.75%+2.05%-14.35%-43.49%-18.38%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
-1.31%+4.66%+2.96%+0.55%-29.93%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
+5.00%+9.88%+1.07%-11.27%-34.15%
InspireMD, Inc. stock logo
NSPR
InspireMD
+0.79%+13.97%+6.90%-35.58%-70.37%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.96
-2.7%
$1.23
$0.85
$2.22
$97.48M1.42732,139 shs904,666 shs
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$37.39
-1.3%
$36.83
$33.27
$60.89
$108.66M0.725,380 shs1,817 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.89
+5.0%
$1.83
$1.60
$4.67
$120.90M1.06504,403 shs630,530 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.74
+2.6%
$0.73
$0.63
$2.60
$34.70M0.81155,330 shs50,091 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-2.75%+2.05%-14.35%-43.49%-18.38%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
-1.31%+4.66%+2.96%+0.55%-29.93%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
+5.00%+9.88%+1.07%-11.27%-34.15%
InspireMD, Inc. stock logo
NSPR
InspireMD
+0.79%+13.97%+6.90%-35.58%-70.37%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hyperfine, Inc. stock logo
HYPR
Hyperfine
2.33
Hold$1.7886.74% Upside
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
2.00
HoldN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$6.63250.53% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.50507.45% Upside

Current Analyst Ratings Breakdown

Latest NSPR, MBOT, KEQU, and HYPR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/22/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
UpgradeHoldStrong-Buy
7/17/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Reiterated RatingSell (D-)
7/14/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Reiterated RatingBuy
7/8/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Reiterated RatingSell (D-)
6/30/2026
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
Reiterated RatingHold (C)
6/3/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Set Price Target$4.00
5/13/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Reiterated RatingBuy
(Data available from 8/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$11.40M8.32N/AN/A$0.42 per share2.27
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$282M0.38$5.88 per share6.36$26.80 per share1.39
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$1.15 per shareN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
$10.85M3.20N/AN/A$1.83 per share0.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$35.57M-$0.41N/AN/AN/A-210.75%-99.81%-64.95%N/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$9.62M$3.2211.61N/AN/A3.41%14.10%5.55%9/16/2026 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$13.14M-$0.26N/AN/AN/AN/A-21.84%-20.71%8/11/2026 (Estimated)
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.73N/AN/AN/A-413.96%-69.42%-57.68%N/A

Latest NSPR, MBOT, KEQU, and HYPR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08N/AN/AN/A$0.33 millionN/A
8/6/2026Q2 2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.09-$0.09N/A-$0.09$4.14 million$3.90 million
6/23/2026Q4 2026
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
N/A$1.14N/A$1.13N/A$71.40 million
5/13/2026Q1 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08-$0.05+$0.03-$0.05$0.30 million$0.11 million
5/12/2026Q1 2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.09-$0.09N/A-$0.09$3.54 million$3.90 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/AN/AN/AN/AN/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hyperfine, Inc. stock logo
HYPR
Hyperfine
0.38
5.52
4.90
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
0.53
2.18
1.55
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.01
22.59
21.93
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05

Institutional Ownership

CompanyInstitutional Ownership
Hyperfine, Inc. stock logo
HYPR
Hyperfine
15.03%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
32.69%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%

Insider Ownership

CompanyInsider Ownership
Hyperfine, Inc. stock logo
HYPR
Hyperfine
26.33%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
14.10%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
InspireMD, Inc. stock logo
NSPR
InspireMD
24.98%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hyperfine, Inc. stock logo
HYPR
Hyperfine
19099.27 million73.13 millionOptionable
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
1,2312.87 million2.46 millionNot Optionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2067.17 million63.98 millionOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5046.84 million18.33 millionOptionable

Recent News About These Companies

InspireMD (NYSE:NSPR) Stock Price Up 0% - Should You Buy?
Lake Street Sticks to Its Buy Rating for InspireMD (NSPR)
InspireMD NSPR Q1 2026 Earnings Transcript
InspireMD (NSPR) Stock Forecast & Price Target

New MarketBeat Followers Over Time

Media Sentiment Over Time

Hyperfine stock logo

Hyperfine NASDAQ:HYPR

$0.96 -0.03 (-2.75%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$0.95 -0.01 (-0.52%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Kewaunee Scientific stock logo

Kewaunee Scientific NASDAQ:KEQU

$37.38 -0.50 (-1.31%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$36.70 -0.69 (-1.85%)
As of 08/7/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$1.89 +0.09 (+5.00%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$1.90 +0.01 (+0.53%)
As of 08/7/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

InspireMD stock logo

InspireMD NYSE:NSPR

$0.74 +0.02 (+2.58%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$0.71 -0.03 (-3.75%)
As of 08/7/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.